30 High-Yield Topics in Pathology for NEET-PG 2026 — The Complete Subject Strategy

Pathology carries roughly 15 direct questions in NEET-PG 2026 — about 60 marks. But that’s just the headline number. Pathology concepts power half the Medicine, Surgery, OBG, and Pediatrics questions on the paper too. Master Pathology and you don’t just bank 60 marks — you raise your accuracy across roughly 120 questions.

The challenge: Pathology’s scope is vast (Robbins is 1,500+ pages) and image-heavy. The students who win don’t read Robbins cover-to-cover — they identify the 30 topics that produce most NEET-PG Pathology questions, master the image atlas, and drill the high-yield value tables. This guide gives you that list.

Why Pathology Is the Multiplier Subject

• ~15 direct questions (about 60 marks) per paper — consistently 3rd or 4th highest weight.
• Massive cross-subject leverage. Every Medicine vignette references underlying pathology. Every Surgery cancer question demands tumour histology. Even OBG (cervical CIN, breast pathology) and Pediatrics (leukaemias) lean on Pathology fundamentals.
• Image-heavy testing. Roughly 30–40% of Pathology MCQs include a histology slide, smear, gross specimen, or IHC pattern. Image recognition is a learnable skill, not innate talent.
• Predictable PYQ patterns. The same handful of high-yield slides (Reed-Sternberg, psammoma bodies, Auer rods, signet-ring cells) appear year after year.

Sub-Specialty Weightage Inside Pathology (Approximate)

The 30 High-Yield Pathology Topics for NEET-PG 2026

★ General Pathology (Topics 1–5)

1. Cell injury and necrosis types. Reversible (hydropic change, fatty change) vs irreversible (membrane breakdown, mitochondrial swelling). Necrosis patterns by tissue — coagulative (most solid organs), liquefactive (brain, abscess), caseous (TB, fungal), fat (pancreatitis, breast trauma), fibrinoid (vasculitis), gangrenous (limb ischaemia).

2. Inflammation — acute vs chronic. Acute (neutrophil-dominant, mediators: histamine, prostaglandins, leukotrienes, complement, kinins) vs chronic (lymphocyte + plasma cell + macrophage). Five cardinal signs — rubor, calor, tumor, dolor, functio laesa.

3. Granulomatous inflammation differential. The big six: TB (caseating, Langhans giant cells), sarcoidosis (non-caseating, Schaumann/asteroid bodies), leprosy, fungal (histoplasma, cryptococcus), foreign body, Crohn’s disease (non-caseating, transmural).

4. Apoptosis vs necrosis. Apoptosis — ATP-dependent, single cells, no inflammation, cell shrinks, intrinsic (mitochondrial / Bcl-2) and extrinsic (Fas/FasL) pathways. Necrosis — ATP-independent, groups of cells, marked inflammation, cell swells. Frequent “all EXCEPT” format.

5. Neoplasia basics. Benign vs malignant features (capsule, mitosis, anaplasia, metastasis), grading vs staging (grade = histology, stage = anatomic spread — TNM), routes of metastasis (lymphatic for carcinomas, haematogenous for sarcomas, transcoelomic for ovarian).

★ Hematopathology (Topics 6–10)

6. Anaemia classification. MCV-based approach: microcytic (iron deficiency, thalassaemia, anaemia of chronic disease, sideroblastic), normocytic (acute blood loss, haemolytic, early IDA), macrocytic (B12 / folate, alcohol, hypothyroidism). Peripheral smear features are the highest-yield image set — hypochromia, target cells, basophilic stippling, hypersegmented neutrophils, schistocytes, spherocytes.

7. Acute leukaemias — AML vs ALL. AML: adults, myeloperoxidase positive, Auer rods (pathognomonic, especially APL/M3 with t(15;17)). ALL: children, TdT positive, CD10/CD19/CD20 (B-ALL) or CD3/CD7 (T-ALL). FAB classification basics.

8. Chronic leukaemias. CML — t(9;22) Philadelphia chromosome, BCR-ABL fusion, imatinib first-line. CLL — mature B-cells, smudge cells on smear, CD5+ / CD19+ / CD23+, common in elderly.

9. Lymphomas. Hodgkin — Reed-Sternberg cells (CD15+ / CD30+), nodular sclerosing is most common subtype, contiguous spread. Non-Hodgkin — B-cell vs T-cell, follicular (t(14;18) BCL-2), Burkitt (t(8;14) c-MYC, “starry sky”), mantle cell (t(11;14) cyclin D1).

10. Multiple myeloma & MGUS. CRAB criteria — hyperCalcaemia, Renal failure, Anaemia, Bone lesions. Bence-Jones proteins (urine light chains), M-spike on serum electrophoresis, “rouleaux” on smear, plasma cell >10% in marrow.

★ Tumour Markers & IHC (Topics 11–13)

11. Tumour markers — clinical use. AFP (HCC, yolk sac, NTDs), CEA (colorectal, monitoring), PSA (prostate, screening + monitoring), CA-125 (ovarian epithelial), CA-19-9 (pancreatic), β-hCG (germ cell, choriocarcinoma, GTD), chromogranin A (neuroendocrine), calcitonin (medullary thyroid). Frequent “most specific” questions.

12. Immunohistochemistry markers. CD20 (B-cell, target of rituximab), CD3 (T-cell), CD30 / CD15 (Reed-Sternberg), HER2/neu (breast, target of trastuzumab), S-100 (melanoma, Schwannoma, Langerhans cells), desmin (rhabdomyosarcoma, smooth muscle), cytokeratin (epithelial), vimentin (mesenchymal).

13. Paraneoplastic syndromes. Small cell lung Ca → SIADH (ADH) or Cushing (ACTH) or Lambert-Eaton. Squamous cell lung Ca → hypercalcaemia (PTHrP). Renal cell Ca → polycythaemia (EPO). Pancreatic Ca → migratory thrombophlebitis (Trousseau). Most often tested via “most likely paraneoplastic.”

★ Renal & GU Pathology (Topics 14–16)

14. Nephrotic syndrome — histology patterns. Minimal change (children, foot process effacement on EM, steroid-responsive), FSGS (HIV, heroin, segmental sclerosis), membranous (subepithelial spikes, anti-PLA2R), membranoproliferative, diabetic nephropathy (Kimmelstiel-Wilson nodules), amyloid (apple-green birefringence).

15. Nephritic syndrome — histology patterns. Post-streptococcal GN (subepithelial humps, low complement), IgA nephropathy (mesangial IgA, recurrent haematuria post URI), RPGN (crescents — type I anti-GBM/Goodpasture, type II immune complex, type III ANCA-pauci-immune), lupus nephritis (ISN/RPS Class I-VI).

16. Renal cell carcinoma. Clear cell is most common (~75%), associated with VHL gene loss on chromosome 3. Classic triad — flank pain + haematuria + abdominal mass (late). Paraneoplastic syndromes — polycythaemia (EPO), hypercalcaemia (PTHrP), hypertension (renin).

★ CVS Pathology (Topics 17–18)

17. Atherosclerosis & myocardial infarction. Response-to-injury hypothesis, plaque components (lipid core, fibrous cap, calcification). MI evolution histology — coagulative necrosis (4–12 hr), neutrophil infiltration (1–3 days), macrophages (3–7 days), granulation tissue (1–3 weeks), scar (>2 months). Tested frequently as timed-event matching.

18. Rheumatic heart disease. Aschoff bodies (pathognomonic granulomas in myocardium), Anitschkow cells (caterpillar nucleus), MacCallum patches (left atrial endocardial thickening), mitral valve most commonly affected, follows Group A strep infection. Jones criteria for diagnosis.

★ Respiratory Pathology (Topic 19)

19. Lung cancers. Adenocarcinoma — most common overall, peripheral, non-smokers / women, EGFR/ALK mutations targetable. Squamous cell — central, smokers, hypercalcaemia (PTHrP), keratin pearls / intercellular bridges. Small cell — central, smokers, neuroendocrine, SIADH/Cushing paraneoplastic, very poor prognosis. Large cell — peripheral, undifferentiated, poor prognosis.

★ GI & Hepatobiliary Pathology (Topics 20–23)

20. IBD pathology — UC vs Crohn’s. UC — continuous from rectum, mucosa + submucosa only, crypt abscesses, lead-pipe colon, toxic megacolon risk. Crohn’s — skip lesions terminal ileum + colon, transmural, non-caseating granulomas, fistulae, fissures, “cobblestone” mucosa, “string sign” on barium.

21. Liver cirrhosis. Causes — alcohol, viral hepatitis (B/C), NAFLD, autoimmune, haemochromatosis, Wilson’s, alpha-1 antitrypsin deficiency. Histology — regenerative nodules + fibrous septae. Complications — portal hypertension, varices, SBP, hepatic encephalopathy, HCC.

22. Viral hepatitis — histology. Acute — ballooning hepatocytes, Councilman bodies (acidophilic apoptotic bodies), lobular disarray. Chronic — portal lymphocytic infiltrate, interface hepatitis, fibrosis. Ground-glass hepatocytes — chronic HBV (HBsAg accumulation).

23. Colorectal cancer. Adenoma-carcinoma sequence (APC → KRAS → p53), high-risk polyps (villous > tubulovillous > tubular, >1 cm, high-grade dysplasia). FAP (APC gene, >100 polyps, 100% cancer risk by 40), HNPCC/Lynch (MMR mismatch repair genes, right-sided, mucinous, Amsterdam criteria).

★ Endocrine & Breast Pathology (Topics 24–26)

24. Thyroid cancers. Papillary (most common, psammoma bodies, “Orphan Annie eye” nuclei, BRAF mutation, lymphatic spread, good prognosis). Follicular (haematogenous spread, capsule + vascular invasion). Medullary (parafollicular C-cells, amyloid deposits, calcitonin secretion, MEN-2A/2B). Anaplastic (elderly, extremely aggressive, <6-month survival).

25. Breast cancer pathology. DCIS (in-situ, no invasion through BM), IDC (most common invasive, ~80%), ILC (single-file infiltration, E-cadherin loss), inflammatory (peau d’orange, dermal lymphatic invasion). Receptor status — ER+, PR+, HER2 — drives prognosis and targeted therapy.

26. Endocrine pathology miscellany. Pheochromocytoma (“rule of 10s,” chromogranin A, zellballen pattern). Adrenal — cortical adenomas (Conn, Cushing), Addison’s causes. Parathyroid — adenoma vs hyperplasia vs carcinoma (~1%).

★ Special Pathology Topics (Topics 27–30)

27. Amyloidosis. AL (light chain, primary, associated with multiple myeloma) vs AA (serum amyloid A, secondary to chronic inflammation — TB, RA, leprosy). Diagnosis — Congo red apple-green birefringence under polarised light. Organs — kidney (proteinuria), heart (restrictive cardiomyopathy), tongue (macroglossia).

28. Pigments and deposits. Lipofuscin (“wear and tear” pigment, brown granules), haemosiderin (iron, Prussian blue stain), melanin (Fontana-Masson stain), bilirubin (jaundice). Dystrophic calcification (in damaged tissue, normal calcium) vs metastatic calcification (in normal tissue, raised calcium).

29. Special stains and their targets. PAS — glycogen, fungi, basement membranes. Congo red — amyloid (apple-green birefringence). Masson trichrome — collagen / fibrosis. Reticulin — reticular fibres (cirrhosis assessment). Prussian blue — iron / haemosiderin. Ziehl-Neelsen — acid-fast bacilli (TB, leprosy). Silver (Warthin-Starry) — spirochaetes (syphilis), Helicobacter.

30. Inclusion bodies and pathognomonic findings. Councilman bodies (viral hepatitis apoptosis), Negri bodies (rabies), Lewy bodies (Parkinson’s, DLB), Mallory hyaline (alcoholic hepatitis), Russell bodies (plasma cell immunoglobulin), Heinz bodies (G6PD deficiency), Howell-Jolly bodies (post-splenectomy nuclear remnants).

Common NEET-PG Pathology Traps to Avoid

• Auer rods are in AML, NOT ALL. Pathognomonic when present. Especially abundant in acute promyelocytic leukaemia (M3) with t(15;17).
• Reed-Sternberg cells are pathognomonic of Hodgkin lymphoma — not just “suggestive.” CD15+ / CD30+, “owl-eye” appearance.
• Psammoma bodies appear in 4 places: papillary thyroid carcinoma, meningioma, papillary serous ovarian carcinoma, mesothelioma. Tested as “all EXCEPT.”
• Grading vs staging confusion. Grade = histological appearance (well/moderately/poorly differentiated). Stage = anatomic spread (TNM). Both matter for prognosis but they’re different.
• Apoptosis vs necrosis — apoptosis is ATP-dependent and non-inflammatory; necrosis is the opposite. Common “all EXCEPT” trap.
• Smudge cells = CLL, not CML. Easy to confuse under exam pressure.
• Apple-green birefringence under polarised light = amyloid. No exceptions in the NEET-PG context.

A 4-Week Pathology Mastery Plan

If you have 4 weeks dedicated to Pathology revision, here’s the breakdown that hits all 30 topics.

End each week with a 40-question mini-test in 26 minutes (NEET-PG section pace), at least 12 of which should be image-based. Pathology is the subject where image-pattern recognition pays the highest dividends — an extra 20 minutes of slide drill per day adds 4 to 6 raw marks to your final score.

Recommended Resources for Pathology

• Primary text: Robbins Basic Pathology (concise) or Robbins and Cotran Pathologic Basis of Disease (deep dive). Selective chapter reads only; don’t attempt full book.
• Image atlas: Robbins Atlas of Pathology or PathologyOutlines.com. Image recognition is at least 30% of Pathology MCQs.
• Indian PG review: One standard review book (Marrow notes, Across PG, Devesh Mishra) for compressed first reading.
• Question bank: The Kinase QBank tags every Pathology question by sub-specialty and PYQ year, with image MCQs flagged separately.

Frequently Asked Questions

How many marks is Pathology in NEET-PG 2026?

Approximately 15 direct questions worth 60 marks. But Pathology concepts power roughly 50% of Medicine, Surgery, and OBG questions too — so the effective leverage is far higher. Master Pathology and you raise accuracy across about 120 of the 200 questions.

Is Robbins necessary for NEET-PG Pathology?

Selectively, yes. Read Robbins for high-yield chapters (Neoplasia, Hematopath, Renal, GI, Endocrine) where deep understanding pays off. For low-yield areas, an Indian PG review book is sufficient. Reading Robbins cover-to-cover is not realistic in your final 6 months.

How important are image-based MCQs in NEET-PG Pathology?

Critical — roughly 30 to 40% of Pathology MCQs include an image (histology slide, smear, gross specimen, IHC pattern). Image recognition is a learnable skill. Drill the high-yield image atlas (Reed-Sternberg, Auer rods, psammoma bodies, smear patterns, granulomas, signet-ring cells) until they’re identifiable at a glance.

Which sub-specialty of Pathology should I start with?

General Pathology + Hematopath first (topics 1–10). They’re foundational for everything else, plus they collectively account for 7–8 of the 15 Pathology questions. After that, tumour markers/IHC, then move to systemic pathology.

How long should I take to finish Pathology for NEET-PG 2026?

First reading: 6–8 weeks (foundation phase). Subject-wise QBank pass: 3 weeks. Final revision: 4 weeks (using the plan above). Total Pathology contact across 12-month prep: roughly 13–15 weeks. Image atlas drill should be a daily 15-minute ritual on top of that.

Are Pathology PYQs enough?

PYQs are necessary but not sufficient. Roughly 30 to 35% of Pathology concepts recur from previous years (rarely verbatim). Pathology PYQs are unusually high-yield because the same image MCQs (Reed-Sternberg, psammoma, Auer rods) repeat across years. Solve last 5 years + add structured QBank for new pattern questions.

What are the highest-yield IHC markers to memorise?

Top 8: CD20 (B-cell), CD3 (T-cell), CD15/CD30 (Reed-Sternberg), HER2 (breast), S-100 (melanoma, Schwannoma), desmin (rhabdomyosarcoma, smooth muscle), cytokeratin (epithelial), vimentin (mesenchymal). Memorise the marker, the cell of origin, and at least one targeted therapy where applicable (e.g., CD20 → rituximab; HER2 → trastuzumab).

Closing Note

Pathology rewards pattern recognition more than any other NEET-PG subject. Once you’ve seen 200 Reed-Sternberg cells, you can’t un-see them. Once you know the four places psammoma bodies appear, you’ll get every variation of that question correct for the rest of your career. The work is front-loaded — the first 6 weeks feel slow as you build the image library — but the back half of Pathology prep is the fastest, highest-yield revision in your entire study plan.

Start with General Pathology and Hematopath, build the image atlas habit, master the 30 topics above, and let the cross-subject leverage compound into the Medicine, Surgery, and OBG questions on exam day.

References:

• PrepLadder. High-Yield Topics for NEET-PG 2026. prepladder.com
• Physics Wallah Live. NEET-PG High-Yield Topics You Should Focus On in 2026. pw.live